| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |